<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="26833">Sulfur</z:chebi> amino acid metabolism was studied in patients with mild to severe forms of <z:hpo ids='HP_0001410'>liver dysfunction</z:hpo> and compared with that of healthy controls </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with mild <z:hpo ids='HP_0001410'>liver dysfunction</z:hpo> (for example, <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e>) had a <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="0" ids="26833">sulfur</z:chebi> amino acid metabolism </plain></SENT>
<SENT sid="2" pm="."><plain>With increased inflammatory activity and <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> (for example, <z:hpo ids='HP_0011010'>chronic</z:hpo> active <z:hpo ids='HP_0012115'>hepatitis</z:hpo>, alcohol-induced <z:hpo ids='HP_0001394'>cirrhosis</z:hpo>, and hepatic <z:hpo ids='HP_0001259'>coma</z:hpo>) a decreased ability to metabolize methionine (to cysteine, with <z:chebi fb="0" ids="17755">cystathionine</z:chebi> accumulation) and cysteine (to inorganic <z:chebi fb="0" ids="16189">sulfate</z:chebi>, with <z:chebi fb="0" ids="16094">thiosulfate</z:chebi> and <z:chebi fb="0" ids="28939">N-acetylcysteine</z:chebi> accumulation) was found </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast, transaminative metabolism of <z:chebi fb="0" ids="26834">sulfur amino acids</z:chebi> was preserved in patients with advanced forms of <z:hpo ids='HP_0001410'>liver dysfunction</z:hpo>, suggesting that transamination of <z:chebi fb="0" ids="26834">sulfur amino acids</z:chebi> is performed not only in the liver but also in extrahepatic tissues </plain></SENT>
<SENT sid="4" pm="."><plain>Some implications of these findings are discussed </plain></SENT>
</text></document>